Back to CRL
BlackRock Finance, Inc. CRL Position History
Charles River Laboratories International, Inc. • Healthcare
Quarters held
19
Latest value
$7.2M
Q2 2024
Peak value
$362.1M
First seen
Q2 2024
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2024 | $33M |
| Q2 2024 | $4.5M |
| Q2 2024 | $6.6M |
| Q2 2024 | $304K |
| Q2 2024 | $1.5M |
| Q2 2024 | $24.2M |
| Q2 2024 | $178.5M |
| Q2 2024 | $362.1M |
| Q2 2024 | $279.9M |
| Q2 2024 | $12.9M |
| Q2 2024 | $22.9M |
| Q2 2024 | $14M |
| Q2 2024 | $18.7M |
| Q2 2024 | $78.2M |
| Q2 2024 | $2.6M |
| Q2 2024 | $1.5M |
| Q2 2024 | $2M |
| Q2 2024 | $474K |
| Q2 2024 | $7.2M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2024 | $7.2M | 34.8K | — | — |
| Q2 2024 | $474K | 2.3K | — | — |
| Q2 2024 | $2M | 9.6K | — | — |
| Q2 2024 | $1.5M | 7.4K | — | — |
| Q2 2024 | $2.6M | 12.4K | — | — |
| Q2 2024 | $78.2M | 378.5K | — | — |
| Q2 2024 | $18.7M | 90.4K | — | — |
| Q2 2024 | $14M | 68.0K | — | — |
| Q2 2024 | $22.9M | 110.8K | — | — |
| Q2 2024 | $12.9M | 62.6K | — | — |
| Q2 2024 | $279.9M | 1.35M | — | — |
| Q2 2024 | $362.1M | 1.75M | — | — |
| Q2 2024 | $178.5M | 863.9K | — | — |
| Q2 2024 | $24.2M | 117.4K | — | — |
| Q2 2024 | $1.5M | 7.4K | — | — |
| Q2 2024 | $304K | 1.5K | — | — |
| Q2 2024 | $6.6M | 32.2K | — | — |
| Q2 2024 | $4.5M | 21.7K | — | — |
| Q2 2024 | $33M | 159.5K | — | — |
Other funds holding CRL
$508.3M
$422.8M
$422.8M
$371.4M
$334.6M
$328.4M
$323.2M
$276.1M